FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
(RTTNews) - Novavax, Inc. (NVAX) Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine ...
SchaeffersResearch.com26d
3 Vaccine Stocks to Watch as Flu Season Approaches
Flu season is almost here, and there is a respiratory syncytial virus (RSV) vaccine update worth monitoring ... standalone influenza shot developed by Novavax Inc (NASDAQ:NVAX).
Novavax Settles Vaccine Supply Agreement Dispute
Novavax ( (NVAX) ) has issued an announcement. Novavax, Inc. and the UK Health Security Agency have reached a settlement to terminate their ...
Medscape23d
Respiratory Syncytial Virus Protein Structure, Function and Implications for Subunit Vaccine Development
Respiratory syncytial virus (RSV) is a negative-stranded ... levels and to elicit a Th1 immune response. Novavax is testing a postfusion F protein vaccine formulated with alum in both older ...
FiercePharma5d
Novavax coughs up $123.8M to settle COVID vaccine supply dispute with UK
Novavax has inked another settlement for a past COVID-19 vaccine supply deal. The Maryland biotech has agreed to pay $123.8 million to end a COVID vaccine supply pact with the UK Health Security ...
Tennessean12d
Moderna, Pfizer or Novavax? How the three Covid-19 vaccines differ according to Yale Medicine
With flu season underway and new, developing COVID-19 strains, health professionals continue to stress the importance of receiving an updated vaccine. On Oct. 23, the Centers for Disease Control ...
NBC Los Angeles17d
Fact Check: Q&A on the 2024-2025 COVID-19 Vaccines
On Aug. 22, the Food and Drug Administration approved and authorized newer formulations of the two mRNA vaccines, from Pfizer ...
USA Today13d
Why COVID-19 vaccinations are recommended, where to get them
2 strain, prompting the approval of updated versions of the Pfizer and Moderna vaccines targeting that particular strain, and the Novavax vaccine ... for the flu and RSV. For people interested ...
MedPage Today12d
RSV Vaccine 90% Effective in High-Risk Adults, Real-World Study Shows
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The bivalent RSV prefusion F vaccine (Abrysvo) demonstrated 90% vaccine effectiveness (VE) in high-risk adults against ...
Reuters5d
Novavax, UK terminate vaccine supply agreement
Novavax (NVAX.O), opens new tab said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency (UKHSA) related to its COVID-19 vaccine supply ...
Yahoo Finance5d
Novavax, UK terminate vaccine supply agreement
(Reuters) -Novavax said on Tuesday that it has entered into a termination and settlement agreement with the UK Health Security Agency (UKHSA) related to its COVID-19 vaccine supply agreement. Under ...